| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.02 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.29 | 0.03 |